A series of random questions answered by Harvard experts.
Disease surveillance network faced ‘existential cliff’ despite proven success. Then came the $100 million.
40 percent of GLP-1 prescriptions go unfilled, study finds
In podcast, experts discuss different types of toxic achievers and the case for embracing your ‘beautiful mess’
Experts weigh in on whether tech poses threat to critical thinking, pointing to cautionary tales in use of other cognitive labor tools
long read
Research highlighting chronic inflammation opens path to treating illness that affects millions of Americans
3 min read
Sven Beckert’s new history traces complex global evolution of system that continues to shift, disrupt even now
8 min read